Cryo-Cell International, Inc. (CCEL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryo-Cell International, Inc. on October 30, 2024, reporting events that occurred on October 29, 2024. The company is incorporated in Delaware and trades on the NYSE American under the symbol CCEL.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a corporate action regarding shareholder distributions.
Material Changes
The primary material event reported is the declaration of a cash dividend by the Board of Directors.
- Dividend Amount: $0.25 per share of common stock.
- Record Date: November 15, 2024.
- Payment Date: Expected November 29, 2024.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or new risk factors. It references a press release dated October 30, 2024, as an exhibit but does not include its text within this summary.
Investor Verification Checklist
- Verify the total number of outstanding shares to calculate the aggregate dividend payout.
- Confirm the record date (November 15, 2024) to ensure eligibility for the dividend.
- Review the referenced press release (Exhibit 99.1) for additional context on the dividend declaration.
- Check the company's cash position in the most recent 10-Q or 10-K to assess liquidity coverage for the dividend payment.